Literature DB >> 2394549

Effect of anisodamine on the microcirculation of the hydronephrotic kidney of rats.

A P Zou1, N Parekh, M Steinhausen.   

Abstract

Anisodamine, an atropine analog, is widely used in China for treatment of acute circulatory shock but mechanisms of its action are not fully known. We investigated the effect of anisodamine on different renal vessels in the hydronephrotic kidney. Anisodamine was added to the tissue bath containing the kidney to produce increasing concentrations from 10(-8) to 10(-3) M. Anisodamine dilated the arcuate artery, interlobular artery and afferent arteriole in a dose dependent manner. The maximal dilation of 15 to 25% in these preglomerular vessels was attained at a concentration of about 10(-5) M. In contrast, the efferent arteriole constricted by about 55% in response to anisodamine. The glomerular blood flow increased by 15 and 40% at anisodamine concentrations of 10(-8) and 10(-5) M respectively. The renal vascular effect of anisodamine could be abolished by the dopamine receptor antagonist haloperidol. Our data indicate that anisodamine is a potent vasodilator of preglomerular renal vessels and that its effect is mediated by activation of the dopaminergic system. The action of anisodamine through a dopaminergic mechanism, as found in the hydronephrotic kidney, may also be involved in its antishock properties.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2394549

Source DB:  PubMed          Journal:  Int J Microcirc Clin Exp        ISSN: 0167-6865


  2 in total

1.  Effectiveness of anisodamine for the treatment of critically ill patients with septic shock (ACIdoSIS study): study protocol for randomized controlled trial.

Authors:  Zhongheng Zhang; Jiancang Zhou; You Shang; Xin'an Wang; Rui Yin; Zhenhua Zhu; Wensen Chen; Xin Tian; Yuetian Yu; Xiangrong Zuo; Kun Chen; Xuqing Ji; Hongying Ni
Journal:  Ann Transl Med       Date:  2015-10

2.  Protective effect of anisodamine in rats with glycerol-induced acute kidney injury.

Authors:  Yun-Feng Li; Bing-Yuan Xu; Ran An; Xin-Fang Du; Kun Yu; Jia-Hua Sun; Guo-Hong Zhang; Wei Wang; Li-Ping An; Guang-Li Wu
Journal:  BMC Nephrol       Date:  2019-06-17       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.